AONC VS INCR Stock Comparison

Performance

AONC
10/100

AONC returned -81.48% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

INCR
10/100

INCR returned -78.13% in the last 12 months. Based on SPY's performance of -13.07%, its performance is below average giving it a score of 10 of 100.

Volatility

AONC
33/100

AONC has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.

INCR
47/100

INCR has had a lower than average amount of volatility over the last 12 months giving it a score of 46 of 100.

Analyst Price Targets

AONC

"Analyst Price Targets" not found for AONC

INCR
71/100

12 analysts offer 12-month price targets for INCR. Together, they have an average target of 0, the most optimistic target put INCR at 0 within 12-months and the most pessimistic has INCR at 0.

Technicals

AONC

"Technicals" not found for AONC

INCR
43/100

INCR receives a 42 of 100 based on 14 indicators. 5 are bullish, 7 are bearish.

Earnings

AONC

"Earnings" not found for AONC

INCR
10/100

INCR has missed earnings 5 times in the last 20 quarters.

Profit

AONC

"Profit" not found for AONC

INCR
60/100

Out of the last 20 quarters, INCR has had 12 profitable quarters and has increased their profits year over year on 8 of them.

All score calculations are broken down here to help you make more informed investing decisions

American Oncology Network, Inc. Class A Common Stock Summary

Nasdaq / AONC

Healthcare

Medical - Care Facilities

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

Intercure Ltd. Ordinary Shares Summary

Nasdaq / INCR

Healthcare

Drug Manufacturers - Specialty & Generic

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Power up your portfolio